Cited by 705Bone Metabolism and DiseasesBone health and osteoporosis researchEstrogen and related hormone effects

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α

Open access

Cenci, Simone, Weitzmann, M. Neale, Roggia, Cristiana, Namba, Noriyuki, Novack, Deborah, Woodring, Jessica, Pacifici, Roberto·2000·Journal of Clinical Investigation

DOI 10.1172/jci11066PMC PMC381439

Open this paper in CoChat — free account Open PDF

Abstract

Physiologic osteoclast renewal results from the differentiation of bone marrow monocytes (BMMs) into osteoclasts, a process induced by the simultaneous stimulation of osteoclast precursors by macrophage colonystimulating factor (M-CSF) and a TNF-related factor known as receptor activator of NF-κB ligand (RANKL; also known as OPGL, TRANCE, or ODF) (1-3).Although upregulation of osteoclast formation is recognized as the main mechanism by which estrogen deficiency induces bone loss (4, 5), the responsible cells and cytokines are not completely understood.Bone marrow stromal cells are essential for physiologic osteoclast renewal because they represent a major source of RANKL and M-CSF and provide a physical support for nascent osteoclasts (6).However, in stimulated conditions additional bone marrow cells contribute to regulate osteoclast formation by producing soluble and membrane-bound pro-and antiosteoclastogenic cytokines.Among them are activated T cells, which stimulate osteoclast formation through increased production of RANKL, a phenomenon that contributes to inflammation-induced bone loss (7).T cells express estrogen receptors, and estrogen directly regulates T-cell function and cytokine production (8-11).Moreover, T-cell subset alterations occur in women with postmenopausal osteoporosis (12, 13).Taken together, these findings suggest that T cells may contribute to enhanced osteoclast formation and induce bone loss not only during inflammation, but also in conditions of estrogen deficiency.In this study we have investigated the role of T cells in ovariectomy-induced bone loss.We report that ovariectomy-enhanced T-cell production of TNF-α, which, acting through the TNF-α receptor p55, augments M-CSF-and RANKL-induced osteoclastogenesis.We also show that ovariectomy failed to induce bone loss, stimulate bone resorption, and increase osteoclast formation in T-cell deficient mice, establishing T cells as essential mediators of the bone-wasting effects of estrogen deficiency in vivo. Methods Experimental protocol.All animal procedures were approved by the Animal Care and Use Committee of Barnes-Jewish Hospital.Wild-type C57BL/6 mice, C57BL/6 homozygous (nu/nu) athymic nude mice (14), and heterozygous (nu/+) euthymic control littermates were obtained from Taconic Farms Inc. (Germantown, New York, USA).C57BL/6 mice lacking either TNF-α receptor 1 (p55 -/-) or TNF-α receptor II (p75 -/-) and wild-type controls of the same genetic background were obtained from Jackson Laboratories (Bar Harbor, Maine, USA).At 5 weeks of age mice were either sham operated or ovariectomized (OVX), and either left untreated or treated with 17β estradiol (0.16 µg/d) for 4 weeks as described (15,16).In vitro osteoclast generation, cytokine neutralization, and TNF-α assay.Bone marrow cells were either cultured unfractionated or depleted of stromal cells by adherence for 12 hours.The nonadherent fraction was used as a source of T cells and BMM precursors and was found to

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci11066

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,345
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,309
Bone histomorphometry : techniques and interpretation
Recker, R. R. (1983) · CRC Press eBooks · Cited by 1,160

Show all 57 references

Research works printed but not linked: 2

Olsen, 1996, Endocr Rev, 17, 369
Fujita, 1984, Miner Electrolyte Metab, 10, 375

Sorted by citations

Items 301–400 of 703

Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect
Koo, H. J., Sohn, E., Kim, Y., Jang, S., Namkoong, S., & Kang, S. C. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.12.008 · Cited by 36
Genetic confirmation for a central role for TNFα in the direct action of thyroid stimulating hormone on the skeleton
Sun, L., Zhu, L.-L., Lü, P., Yuen, T., Li, J., Ma, R., Baliram, R., Moonga, S. S., Liu, P., Zallone, A. Z., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308336110 · Cited by 39
FSH and TSH in the Regulation of Bone Mass: The Pituitary/Immune/Bone Axis
Colaianni, G., Cuscito, C., & Colucci, S. C. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/382698 · Cited by 36
Hormonal Factors and Risk of Psoriasis in Women: A Cohort Study
Wu, S., Cho, E., Li, W., Grodstein, F., & Qureshi, A. A. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2312 · Cited by 36
Minireview: Nuclear Receptor Regulation of Osteoclast and Bone Remodeling
Jin, Z., Li, X., & Wan, Y. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1316 · Cited by 38
Effects of menopause and postmenopausal tibolone treatment on plasma TNFα, IL-4, IL-10, IL-12 cytokine pattern and some bone turnover markers
VURAL, P., Canbaz, M., & Akgül, C. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.01.005 · Cited by 36
Interleukin 7 and estrogen-induced bone loss
Ross, F. P. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00047-x · Cited by 36
Antisense oligonucleotide targeting TNF‐α can suppress co‐cr‐mo particle‐induced osteolysis
Dong, L., Wang, R., Zhu, Y., Wang, C., Diao, H., Zhang, C., Zhao, J., & Zhang, J. (2008) · Journal of Orthopaedic Research® · doi:10.1002/jor.20607 · Cited by 35
Therapeutic role of Punica granatum (pomegranate) seed oil extract on bone turnover and resorption induced in ovariectomized rats
Shaban, N. Z., Talaat, I. M., El-Rashidy, F. H., Hegazy, A. Y., & Sultan, A. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0884-5 · Cited by 35
Oestrogen deficiency modulates particle-induced osteolysis
Nich, C., Langlois, J., Marchadier, A., Vidal, C., Cohen-Solal, M. E., Petite, H., & Hamadouche, M. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3381 · Cited by 34
The Anti-Inflammatory, Phytoestrogenic, and Antioxidative Role ofLabisia pumilain Prevention of Postmenopausal Osteoporosis
Effendy, N. M., Shuid, A. N., Norazlina, M., Isa, N. M., Norliza, M., & Nirwana, S. I. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/706905 · Cited by 34
Human keratinocytes express fractalkine/CX3CL1
Sugaya, M., Nakamura, K., Mitsui, H., Takekoshi, T., Saeki, H., & Tamaki, K. (2003) · Journal of Dermatological Science · doi:10.1016/s0923-1811(03)00031-8 · Cited by 35
Role of Fas and Treg Cells in Fracture Healing as Characterized in the Fas-Deficient (lpr) Mouse Model of Lupus
Al-Sebaei, M. O., Daukss, D. M., Belkina, A. C., Kakar, S., Wigner, N. A., Cusher, D., Graves, D., Einhorn, T., Morgan, E., & Gerstenfeld, L. C. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2169 · Cited by 33
T cell related osteoimmunology in fracture healing: Potential targets for augmenting bone regeneration
Wang, H., Li, Y., Li, H., Xu, Y. K., Jiang, Z., Lu, F., Hu, W., Fan, Y., Lin, S., & Li, G. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.12.004 · Cited by 34
The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.
Yamaguchi, M., & Weitzmann, M. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1043 · Cited by 34
Self-citation
TNF‐α promotes osteoclastogenesis through JNK signaling‐dependent induction of Semaphorin3D expression in estrogen‐deficiency induced osteoporosis
Sang, C., Zhang, J., Zhang, Y., Chen, F., Cao, X., & Guo, L. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25784 · Cited by 34
Characterizing how probiotic Lactobacillus reuteri 6475 and lactobacillic acid mediate suppression of osteoclast differentiation
Quach, D., Parameswaran, N., McCabe, L. R., & Britton, R. A. (2019) · Bone Reports · doi:10.1016/j.bonr.2019.100227 · Cited by 31
Current perspectives of osteoclastogenesis through estrogen modulated immune cell cytokines
Uehara, I. A., Soldi, L. R., & Silva, M. J. B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117921 · Cited by 34
Protective action of aqueous black tea (Camellia sinensis) extract (BTE) against ovariectomy‐induced oxidative stress of mononuclear cells and its associated progression of bone loss
Das, A. S., Mukherjee, M., Das, D., & Mitra, C. (2009) · Phytotherapy Research · doi:10.1002/ptr.2719 · Cited by 34
The unbearable lightness of bone marrow homeostasis
Agas, D., Marchetti, L., Douni, E. K., & Sabbieti, M. G. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.12.004 · Cited by 33
Alterations in the phenotype and function of immune cells in ovariectomy-induced osteopenic mice
García‐Pérez, M. Á., Noguera, I., Hermenegildo, C., Martínez‐Romero, A., Tarín, J. J., & Cano, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei413 · Cited by 32
Osteoprotective Effects of Estrogen in the Maxillary Bone Depend on ERα
Macari, S., Sharma, L. A., Wyatt, A. K., Knowles, P. J., Szawka, R. E., Garlet, G. P., Grattan, D. R., Dias, G. J., & Silva, T. A. (2016) · Journal of Dental Research · doi:10.1177/0022034516633154 · Cited by 32
Serum Calcium-decreasing Factor, Caldecrin, Inhibits Osteoclast Differentiation by Suppression of NFATc1 Activity
Hasegawa, H., Kido, S., Tomomura, M., Fujimoto, K., Ohi, M., Kiyomura, M., Kanegae, H., Inaba, A., Sakagami, H., & Tomomura, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068742 · Cited by 32
Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss
Khosla, S., & Pacifici, R. (2013) · Osteoporosis · doi:10.1016/b978-0-12-415853-5.00046-7 · Cited by 31
Self-citation
The immune cells in modulating osteoclast formation and bone metabolism
Hong, J., Luo, F., Du, X., Xian, F., & Li, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112151 · Cited by 32
Brucella and Osteoarticular Cell Activation: Partners in Crime
Giambartolomei, G. H., Benítez, P. C. A., & Delpino, M. V. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00256 · Cited by 31
Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss
Lehmann, J., Thiele, S., Baschant, U., Rachner, T. D., Niehrs, C., Hofbauer, L. C., & Rauner, M. (2021) · iScience · doi:10.1016/j.isci.2021.102224 · Cited by 32
Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation
Darowish, M., Rahman, R. K., Li, P., Bukata, S., Gelinas, J., Huang, W., Flick, L. M., Schwarz, E., & O'Keefe, R. (2009) · Bone · doi:10.1016/j.bone.2009.06.004 · Cited by 31
Locally administered T cells from mice immunized with lipopolysaccharide (LPS) accelerate LPS-induced bone resorption
Ozaki, Y., Ukai, T., Yamaguchi, M., Yokoyama, M., Haro, E. R. A., Yoshimoto, M., Kaneko, T., Yoshinaga, M., Nakamura, H., Shiraishi, C., et al. (2009) · Bone · doi:10.1016/j.bone.2009.01.375 · Cited by 31
Cells of the Immune System Orchestrate Changes in Bone Cell Function
Wythe, S. E., Nicolaidou, V., & Horwood, N. J. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9764-0 · Cited by 34
Inflammation and skeletal metastasis
Roca, H., & McCauley, L. K. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.75 · Cited by 29
Forum on aging and skeletal health: Summary of the proceedings of an ASBMR workshop
Khosla, S., Bellido, T., Drezner, M. K., Gordon, C. M., Harris, T. B., Kiel, D. P., Kream, B. E., LeBoff, M. S., Lian, J. B., Peterson, C. A., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.488 · Cited by 31
Osteoimmunology: Crosstalk Between T Cells and Osteoclasts in Osteoporosis
Lu, Z., Xiao, P., Liu, S., Huang, C., Li, W., Mao, Y., Xu, Y., & Tian, Y. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09046-1 · Cited by 34
TNF-α and IL10 gene polymorphisms in women with postmenopausal osteoporosis
Kotrych, D., Dziedziejko, V., Safranow, K., Sroczyński, T., Staniszewska, M., Juzyszyn, Z., & Pawlik, A. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.01.037 · Cited by 29
Osteoprotective effect of geraniin against ovariectomy-induced bone loss in rats
Lu, Y., He, B., Zhang, X., Yang, R., Li, S.-D., Song, B., Zhang, Y., Yu, Y., Yan, H., Chen, P., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.11.081 · Cited by 29
Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model
Fathilah, S. N., Mohamed, N., Muhammad, N., Mohamed, I. N., Soelaiman, I. N., & Shuid, A. N. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-217 · Cited by 27
A Comprehensive Analysis of MicroRNAs in Human Osteoporosis
Huai, Y., Zhang, W., Chen, Z., Zhao, F., Wang, W. T., Dang, K., Xue, K., Gao, Y., Jiang, S., Miao, Z., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.516213 · Cited by 32
Alpha-1 Antitrypsin Gene Therapy Ameliorates Bone Loss in Ovariectomy-Induced Osteoporosis Mouse Model
Akbar, M. A., Cao, J., Lu, Y., Nardo, D., Chen, M., Elshikha, A. S., Ahamed, R., Brantly, M., Holliday, L. S., & Song, S. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.029 · Cited by 27
A novel small molecule effectively ameliorates estrogen deficiency-induced osteoporosis by targeting the gut-bone signaling axis
Chen, C., Lei, H., Zhao, Y., Hou, Y. D., Zheng, H., Zhang, C., Cao, Z., Wu, F., Chen, G., Song, Y., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175868 · Cited by 27
Biochemical markers in preclinical models of osteoporosis
Sørensen, M. G., Henriksen, K., Schaller, S., & Karsdal, M. A. (2007) · Biomarkers · doi:10.1080/13547500601070842 · Cited by 30
Plasma Inflammatory Mediators Associated with Bone Metabolism in COPD
Bon, J. M., Zhang, Y., Duncan, S. R., Pilewski, J. M., Zaldonis, D. B., Zeevi, A., McCurry, K. R., Greenspan, S. L., & Sciurba, F. C. (2010) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2010.482114 · Cited by 27
Possible role of S-equol on bone loss via amelioration of inflammatory indices in ovariectomized mice
Nishide, Y., Tadaishi, M., Kobori, M., Tousen, Y., Kato, M., Inada, M., Miyaura, C., & Ishimi, Y. (2013) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.12-123 · Cited by 27
Ziyuglycoside II attenuated OVX mice bone loss via inflammatory responses and regulation of gut microbiota and SCFAs
Zhou, Y., Zhang, Y., Qian, Y., Tang, L., Zhou, T., Xie, Y., Hu, L., Ma, C., Dong, Q., & Sun, P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112027 · Cited by 28
The immune system and postmenopausal osteoporosis
D’Amelio, P. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.822764 · Cited by 26
Role of sphingolipids in the cytoplasmic signaling of estrogens
Sukocheva, O. A., Wadham, C., & Xia, P. (2009) · Steroids · doi:10.1016/j.steroids.2008.12.014 · Cited by 26
Technetium-99 Conjugated with Methylene Diphosphonate Ameliorates Ovariectomy-Induced Osteoporotic Phenotype without Causing Osteonecrosis in the Jaw
Zhao, Y., Wang, L., Liu, Y., Akiyama, K., Chen, C., Atsuta, I., Zhou, T. Y., Duan, X., Jin, Y. J., & Shi, S. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9649-7 · Cited by 26
Gene expression profile induced by ovariectomy in bone marrow of mice: A functional approach to identify new candidate genes associated to osteoporosis risk in women
Pineda, B., Serna, E., Laguna-Fernández, A., Noguera, I., Panach, L., Hermenegildo, C., Tarín, J. J., Cano, A., & García‐Pérez, M. Á. (2014) · Bone · doi:10.1016/j.bone.2014.05.001 · Cited by 26
Dysregulated systemic lymphocytes affect the balance of osteogenic/adipogenic differentiation of bone mesenchymal stem cells after local irradiation
Xu, X., Li, R., Zhou, Y., Zou, Q., Ding, Q., Wang, J., Wei-fang, J., Hua, G., & Jianjun, G. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0527-0 · Cited by 26
Prevention of Trabecular Bone Loss Induced by Estrogen Deficiency by a Selective p38α Inhibitor
Caverzasio, J., Higgins, L., & Ammann, P. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080410 · Cited by 29
Identification of Target Cells for the Genomic Effects of Estrogens in Bone
Windahl, S. H., Lagerquist, M. K., Andersson, N., Jochéms, C., Kallkopf, A., Håkansson, C. H., Inzunza, J., Gustafsson, J.-Α., van der Saag, P. T., Carlsten, H., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0508 · Cited by 26
The role of T cells in osteoporosis, an update.
Zhao, W., Liu, Y., Cahill, C. M., Yang, W., Rogers, J. T., & Huang, X. (2009) · Europe PMC (PubMed Central) · Cited by 26
Denosumab for cancer-related bone loss
Dell’Aquila, E., Armento, G., Iuliani, M., Simonetti, S., D’Onofrio, L., Zeppola, T., Madaudo, C., Russano, M., Citarella, F., Ribelli, G., et al. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1814731 · Cited by 26
Modulation of osteoclast function in bone by the immune system
Quinn, J. M. W., & Saleh, H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.002 · Cited by 28
Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways
Wang, T., Liu, Q., Zhou, L., Yuan, J., Lin, X., Zeng, R., Liang, X., Zhao, J., & Xu, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126039 · Cited by 25
Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy
Miossec, P. (2008) · Biologics · doi:10.2147/btt.s2338 · Cited by 27
Interleukin-10-Producing B Cells Help Suppress Ovariectomy-Mediated Osteoporosis
Wang, Y., Zhang, W., Lim, S.-M., Xu, L., & Jin, J. (2020) · Immune Network · doi:10.4110/in.2020.20.e50 · Cited by 24
Crosstalk between bone and other organs
Yuan, W., & Song, C. (2022) · Medical Review · doi:10.1515/mr-2022-0018 · Cited by 27
Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density
Grahnemo, L., Jochéms, C., Andersson, A., Engdahl, C., Ohlsson, C., Islander, U., & Carlsten, H. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0508 · Cited by 24
Parathyroid Diseases and T Cells
Weitzmann, M. N., & Pacifici, R. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0359-y · Cited by 26
Self-citation
Estrogen Receptor Agonists and Immune System in Ovariectomized Mice
Garcí-Pérez, M. A., del Val, R., Noguera, I., Hermenegildo, C., Pineda, B., Martínez‐Romero, A., & Cano, A. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200601900410 · Cited by 24
Brucella abortus–Infected Macrophages Modulate T Lymphocytes to Promote Osteoclastogenesis via IL-17
Giambartolomei, G. H., Scian, R., Rodríguez, E. V. A., Fossati, C. A., & Delpino, M. V. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.05.029 · Cited by 24
Effects of the Antiestrogen Tamoxifen and the Aromatase Inhibitor Letrozole on Serum Hormones and Bone Characteristics in a Preclinical Tumor Model for Breast Cancer
Núñez, N. P., Jelovac, D., Macedo, L. F., Berrigan, D. A., Perkins, S. N., Hursting, S. D., Barrett, J. C., & Brodie, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0261 · Cited by 23
Modulation of survival in osteoblasts from postmenopausal women
García-Moreno, C., Catalan, M. P., Ortíz, A., Álvarez, L., & de la Piedra, C. (2004) · Bone · doi:10.1016/j.bone.2004.02.021 · Cited by 23
RETRACTED: Appraisal of the Antiarthritic Potential of Prazosin via Inhibition of Proinflammatory Cytokine TNF-α: A Key Player in Rheumatoid Arthritis
Qasim, S., Alamgeer, Saleem, M., Alotaibi, N. H., Bukhari, S. N. A., Alharbi, K. S., Irfan, H. M., & Anwar, R. (2021) · ACS Omega · doi:10.1021/acsomega.0c05698 · Cited by 22
Retracted
Lymphocytes and the Dap12 Adaptor Are Key Regulators of Osteoclast Activation Associated with Gonadal Failure
Anginot, A., Dacquin, R., Mazzorana, M., & Jurdic, P. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000585 · Cited by 22
Three-dimensional visualization and pathologic characteristics of cartilage and subchondral bone changes in the lumbar facet joint of an ovariectomized mouse model
Wu, T., Ni, S., Cao, Y. B., Liao, S., Hu, J., & Duan, C. (2017) · The Spine Journal · doi:10.1016/j.spinee.2017.11.009 · Cited by 22
Regulation of bone metabolism by megakaryocytes in a paracrine manner
Lee, Y., Kwak, M. K., Moon, S.-A., Choi, Y. J., Baek, J. E., Park, S. Y., Kim, B., Lee, S. H., & Koh, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-59250-6 · Cited by 22
Compressive mechanical force augments osteoclastogenesis by bone marrow macrophages through activation of c‐Fms‐mediated signaling
Cho, E., Lee, K.-S., Son, Y.-O., Jang, Y., Lee, S.-Y., Kwak, S., Yang, Y.-M., Park, S.-M., & Lee, J.-C. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22849 · Cited by 19
Substance P blocks ovariectomy-induced bone loss by modulating inflammation and potentiating stem cell function
Piao, J., Park, J. S., Hwang, D. Y., Son, Y., & Hong, H. S. (2020) · Aging · doi:10.18632/aging.104008 · Cited by 21
Role of the immune system in postmenopausal bone loss
Weitzmann, M., & Pacifici, R. (2005) · Current Osteoporosis Reports · doi:10.1007/s11914-005-0016-8 · Cited by 25
Self-citation
Fluorosis increases the risk of postmenopausal osteoporosis by stimulating interferon γ
Lv, Y., Kang, L., & Wu, G. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.083 · Cited by 21
Regulatory network mediated by RBP‐J/NFATc1‐miR182 controls inflammatory bone resorption
Inoue, K., Hu, X., & Zhao, B. (2019) · The FASEB Journal · doi:10.1096/fj.201902227r · Cited by 21
Osteoporotic Conditions Influence the Activity of Adipose-Derived Stem Cells
Park, J. S., Piao, J., Park, G., Yoo, K. S., & Hong, H. S. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00289-x · Cited by 21
Antioxidant and Anti-inflammatory Extracts From Sea Cucumbers and Tunicates Induce a Pro-osteogenic Effect in Zebrafish Larvae
Carletti, A., Cardoso, C. L., Lobo, J., Sales, S. D. S., Juliao, D., Ferreira, I., Chaínho, P., Dionísio, M. A., Gaudêncio, M. J., Afonso, C. M., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.888360 · Cited by 28
MHC Class II Transactivator Is an In Vivo Regulator of Osteoclast Differentiation and Bone Homeostasis Co-opted From Adaptive Immunity
Benasciutti, E., Mariani, E., Oliva, L., Scolari, M. P., Perilli, E., Barras, E., Milan, E., Orfanelli, U., Fazzalari, N. L., Campana, L., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2090 · Cited by 23
Self-citation
Long-term changes in rat hematopoietic and other physiological systems after high-energy iron ion irradiation
Gridley, D. S., Obenaus, A., Bateman, T. A., & Pecaut, M. J. (2008) · International Journal of Radiation Biology · doi:10.1080/09553000802203614 · Cited by 21
Increased Fat Due to Estrogen Deficiency Induces Bone Loss by Elevating Monocyte Chemoattractant Protein-1 (MCP-1) Production
Kim, Y.-Y., Kim, S., Oh, S.-R., Sul, O., Lee, H., Kim, H., Kim, S., & Choi, H. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0027-x · Cited by 20
P2X7Rs: new therapeutic targets for osteoporosis
Huang, H., He, Y.-M., Lin, M., Wang, Y., Zhang, X., Li, L., & He, X. (2022) · Purinergic Signalling · doi:10.1007/s11302-021-09836-0 · Cited by 21
Targeting the osteoclastogenic cytokine IL-9 as a novel immunotherapeutic strategy in mitigating inflammatory bone loss in post-menopausal osteoporosis
Sapra, L., Saini, C., Sharma, S., Nanda, D., Nilakhe, A., Chattopadhyay, N., Meena, A. S., Mishra, P. K., Gupta, S., Garg, B., et al. (2024) · JBMR Plus · doi:10.1093/jbmrpl/ziae120 · Cited by 22
Gene expression profiles of disc tissues and peripheral blood mononuclear cells from patients with degenerative discs
Zhang, Y., Guo, X., Sun, Z., Jia, G., Xu, P., & Wang, S. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0120-4 · Cited by 20
Structure and Function of Tumor Necrosis Factor (TNF) at the Cell Surface
Wu, H., & Hymowitz, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00040-1 · Cited by 25
LIGHT/TNFSF14 regulates estrogen deficiency‐induced bone loss
Brunetti, G., Storlino, G., Oranger, A., Colaianni, G., Faienza, M. F., Ingravallo, G., Comite, M. D., Reseland, J. E., Celi, M., Tarantino, U., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5385 · Cited by 21
The IAP Antagonist SM-164 Eliminates Triple-Negative Breast Cancer Metastasis to Bone and Lung in Mice
Lei, W., Duan, R., Li, J., Liu, X. Z., Huston, A. J., Boyce, B. F., & Yao, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-64018-z · Cited by 21
Protective effect of kobophenol A on nitric oxide-induced cell apoptosis in human osteoblast-like MG-63 cells: Involvement of JNK, NF-κB and AP-1 pathways
Lee, S., Kwak, J.-H., Park, D.-S., & Pyo, S. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.04.004 · Cited by 20
The effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: Potential steroid-sparing role for DHEA
Harding, G., Mak, Y. T., Evans, B. A. J., Cheung, J., MacDonald, D., & Hampson, G. (2006) · Cytokine · doi:10.1016/j.cyto.2006.10.012 · Cited by 20
Effects of local point source polychlorinated biphenyl (PCB) contamination on bone mineral density in deer mice (Peromyscus maniculatus)
Johnson, K. E., Knopper, L. D., Schneider, D. C., Ollson, C. A., & Reimer, K. J. (2009) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2009.06.004 · Cited by 20
Age-associated (cardio)metabolic diseases and cross-talk between adipose tissue and skeleton: endocrine aspects
Migliaccio, S., Greco, E. A., Aversa, A., & Lenzi, A. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0030 · Cited by 23
Bone growth stimulators New tools for treating bone loss and mending fractures
Whitfield, J. F., Morley, P., & Willick, G. E. (2002) · Vitamins and hormones · doi:10.1016/s0083-6729(02)65059-9 · Cited by 21
Bone marrow neutrophil progenitors suppress osteoclast formation in murine cortical and trabecular bone
Isojima, T., Crimeen‐Irwin, B., McGregor, N. E., Chai, R. C. C., Poulton, I. J., Walker, E. C., Dutt, M., Parker, B. L., & Sims, N. A. (2025) · Blood · doi:10.1182/blood.2025028310 · Cited by 19
Impaired bone formation in ovariectomized mice reduces implant integration as indicated by longitudinal in vivo micro-computed tomography
Li, Z., Kuhn, G. A., Schirmer, M., Müller, R., & Ruffoni, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184835 · Cited by 19
Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis
Madel, M., Halper, J., Ibáñez, L., Claire, L., Rouleau, M., Boutin, A., Mahler, A., Pontier-Bres, R., Ciucci, T., Topi, M., et al. (2023) · eLife · doi:10.7554/elife.82037 · Cited by 21
WHIM Syndrome-linked CXCR4 mutations drive osteoporosis
Anginot, A., Nguyen, J., Nader, Z. A., Rondeau, V., Bonaud, A., Kalogeraki, M., Boutin, A., Lemos, J. P., Bisio, V., Koenen, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37791-4 · Cited by 20
Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health
Guimarães, G. C., Coelho, J. B. C., Silva, J. G. O., de Sant’Ana, A. C. C., de Sá, C. A. C., Moreno, J. M., Reis, L. M., & Guimarães, C. S. D. O. (2023) · Osteoporosis International · doi:10.1007/s00198-023-06991-5 · Cited by 19
Binding Kinetics of a Fluorescently Labeled Bisphosphonate as a Tool for Dynamic Monitoring of Bone Mineral Deposition In Vivo
Tower, R. J., Campbell, G. M., Müller, M., Will, O., Glüer, C., & Tiwari, S. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2224 · Cited by 19
Pathophysiology and Clinical Manifestations of Osteoporosis
Becker, C. (2008) · Clinical cornerstone · doi:10.1016/s1098-3597(09)62038-x · Cited by 19
Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency
Thouverey, C., & Caverzasio, J. (2015) · Endocrinology · doi:10.1210/en.2015-1669 · Cited by 19
Immune system and bone metabolism: Does thymectomy influence postmenopausal bone loss in humans?
D’Amelio, P., Grimaldi, A., Bernabei, P., Pescarmona, G., & Isaia, G. (2006) · Bone · doi:10.1016/j.bone.2006.03.009 · Cited by 19
T Cell-Derived Apoptotic Extracellular Vesicles Ameliorate Bone Loss via CD39 and CD73-Mediated ATP Hydrolysis
Yang, X., Zhou, Y., Zhou, F., Bao, L., Wang, Z., Li, Z., Ding, F., Kuang, H., Liu, H., Tan, S., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s491222 · Cited by 18
The role of secreted osteoclastogenic factor of activated T cells in bone remodeling
Zhang, R., Peng, S., & Zhu, G. (2022) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2022.07.001 · Cited by 19
Tissue adaptation of CD4 T lymphocytes in homeostasis and cancer
Pereira, M. V. A., Galvani, R. G. A., Gonçalves-Silva, T., de Vasconcelos, Z. F. M., & Bonomo, A. C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1379376 · Cited by 19

Authors: Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R.
Affiliations: Barnes-Jewish Hospital (US)
Corresponding author: Pacifici, Roberto
ORCID: Cenci, Simone
Weitzmann, M. Neale
Roggia, Cristiana
Namba, Noriyuki
Novack, Deborah
Pacifici, Roberto
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2000-11-15
Volume: 106
Issue: 10
Pages: 1229-1237
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci11066
PMC: PMC381439
OpenAlex: W2133281510
Cited by: 705
References: 57
Citations by year: 2026: 30 · 2025: 30 · 2024: 14 · 2023: 25 · 2022: 23 · 2021: 27 · 2020: 35 · 2019: 25 · 2018: 19 · 2017: 34 · 2016: 33 · 2015: 37 · 2014: 32 · 2013: 32 · 2012: 28
FWCI: 7.12
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Arthritis Foundation
Eli Lilly and Company
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041412, AR41412, AR-13534)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords: estrogen deficiency, bone loss, ovariectomy, T cells, TNF-α, osteoclastogenesis, RANKL, macrophage colony-stimulating factor, TNF receptor p55, postmenopausal osteoporosis, bone resorption, nude mice, estrogen receptor, mesenchymal stem cells, T cell deficiency
MeSH terms: Animals, Bone Resorption, Carrier Proteins, Cells, Cultured, Estrogens, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Nude, Osteoclasts, Ovariectomy, T-Lymphocytes, Tumor Necrosis Factor-alpha, Antigens, CD, Macrophage Colony-Stimulating Factor, Receptors, Tumor Necrosis Factor, Mice, Knockout, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks